Gail D. Lewis Phillips

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

Gail D. Lewis Phillips, Guangmin Li, Debra L. Dugger et al. · Cancer Research · 2008 · 1.6K citations

Drug Targeting, Breast Oncology, Disulfide Linkers +12

Identification of Heregulin, a Specific Activator of p185 ^erbB2

William E. Holmes, Mark X. Sliwkowski, Robert W. Akita et al. · Science · 1992 · 958 citations

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

Teemu T. Junttila, Robert W. Akita, Kathryn L. Parsons et al. · Cancer Cell · 2009 · 822 citations · Full text

Molecular Pharmacology, Signaling Pathway, Medicine +10

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

Mark D. Pegram, Sheree Hsu, Gail D. Lewis Phillips et al. · Oncogene · 1999 · 687 citations

Inhibitory Effects, Oncology, Breast Oncology +10

Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1

Jennifer LeCouter, Dirk Moritz, Bing Li et al. · Science · 2003 · 669 citations

Immunology, Pathology, Inflammation +22